KraneShares MSCI All China Health Care Index ETF KURE
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.65%
- Net assets
- $71.2M
- Holdings
- 63
- 12-month distribution yield
- 3.91%
- Asset class
- Equity
KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund listed on NYSE Arca in the United States, issued by KraneShares. Its category is Equity · International (equity). Its last price was US$18.30 on 20 Oct 2026. Its net expense ratio is 0.65% a year, from its prospectus dated 1 Aug 2025. It reported net assets of US$71.23 million as of 30 Jun 2026. Its latest holdings report lists 63 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.72 a unit, a 12-month distribution yield of 3.91%, paid yearly.
Fees
- Total annual operating expenses (gross)
- 0.79%
- Net, after fee waivers or reimbursements
- 0.65%
- Management fee
- 0.78%
- Prospectus date
- 1 Aug 2025
- Filed with the SEC
- 29 Jul 2025
Size and reporting
- Net assets
- $71,227,168
- Total assets
- $74,173,901
- Holdings as of
- 30 Jun 2026
- Report made public
- 28 Aug 2026 (59 days after the month end)
Top holdings
Largest 25 of 63 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | BeOne Medicines AG BEONE MEDICINES LTD-H COMMON STOCK | CH1391448177 | 8.84% | $6.3M | Equity (common) | Hong Kong | HKD |
| 2 | INNOVENT BIOLOGICS, INC. INNOVENT BIOLOGICS INC COMMON STOCK | KYG4818G1010 | 8.80% | $6.3M | Equity (common) | Hong Kong | HKD |
| 3 | WUXI BIOLOGICS (CAYMAN) INC. WUXI BIOLOGICS CAYMAN INC COMMON STOCK | KYG970081173 | 7.51% | $5.4M | Equity (common) | Hong Kong | HKD |
| 4 | WuXi AppTec Co., Ltd. WUXI APPTEC CO LTD-A COMMON STOCK | CNE1000031K4 | 5.79% | $4.1M | Equity (common) | China | CNY |
| 5 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd JIANGSU HENGRUI PHARMACEUT-A COMMON STOCK | CNE0000014W7 | 4.59% | $3.3M | Equity (common) | China | CNY |
| 6 | Shenzhen Mindray Bio-Medical Electronics Co Ltd SHENZHEN MINDRAY BIO-MEDIC-A COMMON STOCK | CNE100003G67 | 4.27% | $3.0M | Equity (common) | China | CNY |
| 7 | Akeso Inc AKESO INC COMMON STOCK | KYG0146B1032 | 3.72% | $2.6M | Equity (common) | Hong Kong | HKD |
| 8 | CSPC PHARMACEUTICAL GROUP LIMITED CSPC PHARMACEUTICAL GROUP LT COMMON STOCK | HK1093012172 | 3.68% | $2.6M | Equity (common) | Hong Kong | HKD |
| 9 | Invesco Government & Agency Portfolio | US8252528851 | 3.55% | $2.5M | Short-term investment vehicles (cash funds) | United States | USD |
| 10 | SINO BIOPHARMACEUTICAL LIMITED SINO BIOPHARMACEUTICAL COMMON STOCK | KYG8167W1380 | 3.39% | $2.4M | Equity (common) | Hong Kong | HKD |
| 11 | WuXi AppTec Co., Ltd. WUXI APPTEC CO LTD-H COMMON STOCK | CNE100003F19 | 3.35% | $2.4M | Equity (common) | Hong Kong | HKD |
| 12 | HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED HANSOH PHARMACEUTICAL GROUP COMMON STOCK | KYG549581067 | 2.85% | $2.0M | Equity (common) | Hong Kong | HKD |
| 13 | 3SBio Inc. 3SBIO INC COMMON STOCK | KYG8875G1029 | 2.49% | $1.8M | Equity (common) | Hong Kong | HKD |
| 14 | YUNNAN BAIYAO GROUP CO., LTD YUNNAN BAIYAO GROUP CO LTD-A COMMON STOCK | CNE0000008X7 | 2.30% | $1.6M | Equity (common) | China | CNY |
| 15 | Shanghai United Imaging Healthcare Co., Ltd. SHANGHAI UNITED IMAGING HE-A COMMON STOCK | CNE100005PN5 | 2.27% | $1.6M | Equity (common) | China | CNY |
| 16 | Aier Eye Hospital Group Co., Ltd. AIER EYE HOSPITAL GROUP CO-A COMMON STOCK | CNE100000GR6 | 2.10% | $1.5M | Equity (common) | China | CNY |
| 17 | Sichuan Biokin Pharmaceutical Co Ltd SICHUAN BIOKIN PHARMACEUTI-A COMMON STOCK | CNE100006FN4 | 1.97% | $1.4M | Equity (common) | China | CNY |
| 18 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd SICHUAN KELUN-BIOTECH BIOP-H COMMON STOCK | CNE1000062J1 | 1.85% | $1.3M | Equity (common) | Hong Kong | HKD |
| 19 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. ZHANGZHOU PIENTZEHUANG PHA-A COMMON STOCK | CNE000001F21 | 1.73% | $1.2M | Equity (common) | China | CNY |
| 20 | SINOPHARM GROUP CO. LTD. SINOPHARM GROUP CO-H COMMON STOCK | CNE100000FN7 | 1.67% | $1.2M | Equity (common) | Hong Kong | HKD |
| 21 | Sichuan Kelun Pharmaceutical Co., Ltd. SICHUAN KELUN PHARMACEUTIC-A COMMON STOCK | CNE100000PW7 | 1.55% | $1.1M | Equity (common) | China | CNY |
| 22 | Haisco Pharmaceutical Group Co., Ltd. HAISCO PHARMACEUTICAL GROU-A COMMON STOCK | CNE100001BC7 | 1.53% | $1.1M | Equity (common) | China | CNY |
| 23 | HUADONG MEDICINE CO., LTD HUADONG MEDICINE CO LTD-A COMMON STOCK | CNE0000011S1 | 1.36% | $969K | Equity (common) | China | CNY |
| 24 | WuXi XDC Cayman Inc WUXI XDC CAYMAN INC COMMON STOCK | KYG9808A1058 | 1.35% | $964K | Equity (common) | Hong Kong | HKD |
| 25 | Shanghai Allist Pharmaceuticals Co Ltd SHANGHAI ALLIST PHARMACEUT-A COMMON STOCK | CNE100005XJ7 | 1.34% | $954K | Equity (common) | China | CNY |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.67% | |
| Short-term investment vehicles (cash funds) | 3.55% |
Country
| Country | Weight | Bar |
|---|---|---|
| Hong Kong | 52.67% | |
| China | 45.73% | |
| United States | 4.82% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| Hong Kong dollar (HKD) | 52.67% | |
| Chinese yuan (CNY) | 45.73% | |
| US dollar (USD) | 4.82% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 1.28% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.7150
- 12-month yield
- 3.91%
- Frequency
- Yearly
- Latest ex-date
- 22 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.7150) ÷ latest price ($18.30) × 100 = 3.91%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (5 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Dec 2025 | $0.7150 |
| 17 Dec 2024 | $0.1840 |
| 18 Dec 2023 | $0.1130 |
| 28 Dec 2022 | $0.0100 |
| 29 Dec 2021 | $4.0540 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000059796) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- KURE and VXUS Vanguard Total International Stock ETF
- KURE and VEA Vanguard FTSE Developed Markets ETF
- KURE and IEFA iShares Core MSCI EAFE ETF
- KURE and VWO Vanguard FTSE Emerging Markets ETF